The Genetic Toxicology Testing market size is USD 1.8 Bn in 2026.
The Genetic Toxicology Testing market is projected to grow at a CAGR of 10% by 2033.
The market growth drivers include increased pharmaceutical R&D activities, rising demand for humanized animal models, and growing prevalence of chronic diseases.
North America is a dominating region for the Genetic Toxicology Testing market.
Thermo Fisher Scientific, Agilent Technologies, Charles River Laboratories, Eurofins Scientific, and Danaher Corporation are some leading industry players in the Genetic Toxicology Testing market.